Roger J. Dreiling MD
Interventional Cardiology, Non-Invasive Cardiology
Medical Director, Shaw Heart and Vascular Institute
Join to View Full Profile
2700 NW Stewart pkwyRoseburg, OR 97471
Phone+1 541-677-1555
Dr. Dreiling is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Roger Dreiling is a cardiologist in Roseburg, OR and is affiliated with Mercy Medical Center in Roseburg, Oregon. He is the Medical Director of Shaw Heart and Vascular Institute. Dr Dreiling has over 40 years of interventional cardiology experience. He received his medical degree from University of Kansas School of Medicine. He specializes in interventional cardiology and non-invasive cardiology and is experienced in interventional cardiology and cardiac critical care. He has more than 10 publications and over 450 citings.
Education & Training
University of Kansas School of MedicineFellowship, Cardiovascular Disease, 1982 - 1984- University of Kansas School of MedicineResidency, Internal Medicine, 1978 - 1982
- University of Kansas School of MedicineClass of 1978
Certifications & Licensure
AZ State Medical License 2006 - Present
KS State Medical License 1979 - 2025
OR State Medical License 2014 - 2025
CA State Medical License 2006 - 2024
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 160 citationsLong-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization. EXCITE Trial Investigators. Evaluation of Oral Xemi...William W. O'Neill, P. W. Serruys, M. Knudtson, G. A. Van Es, Gerald C. Timmis
The New England Journal of Medicine. 2000-05-04 - 79 citationsPharmacodynamic Efficacy, Clinical Safety, and Outcomes After Prolonged Platelet Glycoprotein IIb/IIIa Receptor Blockade With Oral Xemilofiban: Results of a Multicente...Dean J. Kereiakes, Neal S. Kleiman, James J. Ferguson, A. R. Zaki Masud, Thomas M. Broderick
Circulation. 1998-09-29 - 4 citationsTwo-dimensional echocardiographic features of multiple right atrial myxomas.Joseph R. Gladden, Roger J. Dreiling, Steven B. Gollub, Thomas J. Bixler, Marvin Dunn
The American Journal of Cardiology. 1983-12-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
